Therapies aimed at restoring normal autophagy in cystic fibrosis patients have recently been reviewed [58], and treatment of mice harboring mutations in the CFTR with the autophagy inducer rapamycin has been shown to enhance clearance of the cystic fibrosis pathogen Burkhoderia cenocepacia from the lungs [40]. This evidence concerns the gene CFTR and cystic fibrosis.